Analytical Data
-
Gene name
MCP4
- Application
-
Alternative Names
MCP4；MCP4；NCC1；SCYA13；C-C motif chemokine 13
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q99616
-
Expression Region
24-98aa
-
AA Sequence
QPDALNVPST CCFTFSSKKI SLQRLKSYVI TTSRCPQKAV IFRTKLGKEI CADPKEKWVQ NYMKHLGRKA HTLKT
-
Molecular Weight
9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MCP4, or Major Capsid Protein 4, is a critical component of various viral capsids, particularly in the context of bacteriophages and certain animal viruses. The study of MCP4 recombinant proteins has gained significant attention due to its potential applications in virology, immunology, and biotechnology. Research in this area is driven by the need to understand the structural and functional properties of MCP4, which plays a pivotal role in viral assembly, protection of viral genetic material, and interaction with host cells. Recombinant MCP4 proteins are produced using advanced molecular cloning techniques and expression systems, enabling the characterization of their physicochemical properties and functionality. These studies provide insights into viral life cycles, and antibody production, and pave the way for the development of novel antiviral strategies. Furthermore, the ability to engineer MCP4 proteins opens avenues for their use in vaccine development, where they can serve as carriers for antigen delivery or as platforms for study in nanotechnology applications. The exploration of MCP4 also raises important questions regarding the immune response elicited by these proteins and their potential in therapeutic interventions against viral infections. Overall, research on MCP4 recombinant proteins is vital in understanding viral pathogenesis and enhancing current strategies in disease prevention and treatment.
